M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.06 USD -1.6%
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MoonLake Immunotherapeutics
Cash Equivalents Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Cash Equivalents
$451.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Cash Equivalents
$278.6m
CAGR 3-Years
-14%
CAGR 5-Years
15%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Cash Equivalents
CHf51.6m
CAGR 3-Years
-21%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Cash Equivalents
CHf218.7k
CAGR 3-Years
-64%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Cash Equivalents?
Cash Equivalents
451.2m USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Cash Equivalents amounts to 451.2m USD.

What is MoonLake Immunotherapeutics's Cash Equivalents growth rate?
Cash Equivalents CAGR 1Y
1 042%

Over the last year, the Cash Equivalents growth was 1 042%.

Back to Top